Download PDF
Horm Metab Res 2019; 51(05): 309-314
DOI: 10.1055/a-0879-5122
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Pattern of Lipid Abnormalities Among South Asian Indians With Cushing’s Syndrome and the Short Term Impact of Surgical Correction of Hypercortisolism

Atul Dhingra
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
,
Mohd Ashraf Ganie
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
,
Pramila Dharmshaktu
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
,
Semanti Chakraborty
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
,
Viveka P. Jyotsna
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
,
Nandita Gupta
1   Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations
Further Information

Publication History

received 22 March 2018

accepted 12 March 2019

Publication Date:
09 May 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Atherosclerotic cardiovascular events are one of the common causes of mortality in patients with Cushing’s syndrome (CS). Atherogenic dyslipidemia is more common among South Asian Indians as compared to other ethnicities and is likely to worsen among patients with CS. This retrospective study was done over 5 years at a single institute to evaluate the pattern of lipid abnormalities in subjects with CS and the changes in lipid parameters after surgical control of hypercortisolemia. The study was done in two parts. In the first part, records of patients with CS diagnosed over 3 years were retrospectively reviewed. Hormonal and metabolic parameters including fasting plasma glucose (FPG), post prandial plasma glucose (PPPG), HbA1c, serum lipids, serum cortisol and plasma ACTH were recorded. In the second part, lipid parameters were rechecked among patients who underwent surgery and a median follow up of 4±2 months after remission. Out of the 126 patients diagnosed with endogenous CS over 3 years, 100 patients were eligible for inclusion in the study. At baseline, sixty five (65%) patients had dyslipidemia as defined by the NCEP-ATPIII criteria. 47 out of 63 (74.6%) subjects achieved remission after surgical management of CS. 32 (68.1%) of these patients had dyslipidemia prior to surgery. After excluding 1 death, 26 of 46 (56.5%) subjects had dyslipidemia after the follow up period. Lipid abnormalities are common among South Asian Indian subjects with endogenous CS and the pattern persists in most of them, 3 months after surgical correction of hypercortisolism.

Key words

lipid abnormalities - Cushing syndrome - hypercortisolism
 

  • References

  • 1 Arnaldi G, Angeli A, Atkinson AB. et al. Diagnosis and complications of Cushing’s syndrome: A consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602
    CrossrefPubMedGoogle Scholar
  • 2 Samra JS, Clark ML, Humphreys SM. et al. Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab 1998; 83: 626-631
    PubMedGoogle Scholar
  • 3 Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: Towards expansion of therapeutic options?. Eur J Clin Invest 2009; 39: 81-93
    CrossrefPubMedGoogle Scholar
  • 4 Taskinen MR, Nikkilä EA, Pelkonen R. et al. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing’s syndrome. J Clin Endocrinol Metab 1983; 57: 619-626
    CrossrefPubMedGoogle Scholar
  • 5 Greenman Y. Management of Dyslipidemia in Cushing’s Syndrome. Neuroendocrinology 2010; 92 (Suppl. 01) 91-95
    CrossrefPubMedGoogle Scholar
  • 6 Faggiano A, Pivonello R, Spiezia S. et al. Cardiovascular risk factor and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 2003; 88: 2527-2533
    CrossrefPubMedGoogle Scholar
  • 7 Mancini T, Kola B, Mantero F. et al. High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol 2004; 61: 768-777
    CrossrefPubMedGoogle Scholar
  • 8 Tauchmanovà L, Rossi R, Biondi B. et al. Patients with subclinical Cushing’s syndrome due to adrenal adenoma have increased cardiovascular risk. J Clin Endocrinol Metab 2002; 87: 4872-4878
    CrossrefPubMedGoogle Scholar
  • 9 Misra A, Khurana L. The metabolic syndrome in south asians: Epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009; 7: 497-514
    CrossrefPubMedGoogle Scholar
  • 10 Dhingra V, Chatterjee A, Guleria R. et al. Adverse physical activity pattern in urbanadolescents. J Assoc Physicians India 2002; 50: 1521
    PubMedGoogle Scholar
  • 11 Misra A, Vikram NK. Insulin resistance syndrome(metabolic syndrome) and obesity in Asian Indians:evidence and implications. Nutrition 2004; 20: 482-491
    CrossrefPubMedGoogle Scholar
  • 12 Luthra K, Bharghav B, Chabbra S. et al. Apolipoprotein Epolymorphism in Northern Indian patients with coronaryheart disease: Phenotype distribution and relation to serumlipids and lipoproteins. Mol Cell Biochem 2002; 232: 97-102
    CrossrefPubMedGoogle Scholar
  • 13 American Diabetes Association . Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2014; 37: S81-S90
    CrossrefPubMedGoogle Scholar
  • 14 WHO Expert Consultation . Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163. Review. Erratum: Lancet 2004; 363 (9412): 902
    CrossrefPubMedGoogle Scholar
  • 15 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (AdultTreatment Panel III) . Third Report of the National Cholesterol EducationProgram (NCEP) Expert Panel on Detection, Evaluation, and Treatment of HighBlood Cholesterol in Adults (Adult Treatment Panel III)—final report. Circulation 2002; 106: 3143-3421
    CrossrefPubMedGoogle Scholar
  • 16 Clayton RN, Raskauskiene D, Reulen RC. et al. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: Audit and meta-analysis of literature. J Clin Endocrinol Metab 2011; 96: 632-642
    CrossrefPubMedGoogle Scholar
  • 17 Hassan-Smith ZK, Sherlock M, Reulen RC. et al. Outcome of Cushing’s disease following transsphenoidal surgery in a singlecentre over 20 years. J Clin Endocrinol Metab 2012; 97: 1194-1201
    CrossrefPubMedGoogle Scholar
  • 18 Bolland MJ, Holdaway IM, Berkeley JE. et al. Mortality and morbidity in Cushing's syndrome in NewZealand. Clin Endocrinol (Oxf) 2011; 75: 436-442
    CrossrefPubMedGoogle Scholar
  • 19 Howlett TA, Drury PL, Perry L. et al. Diagnosis andmanagement of ACTH-dependent Cushing’s syndrome: comparison of the features inectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 1986; 24: 699
    CrossrefPubMedGoogle Scholar
  • 20 Newell-Price J, Trainer P, Besser M. et al. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998; 19: 647-672
    PubMedGoogle Scholar
  • 21 Geer EB, Shen W, Strohmayer E. et al. Body composition and cardiovascular risk markers after remission of Cushing’s disease: a prospectivestudy using whole-body MRI. J Clin Endocrinol Metab 2012; 97: 1702-1711
    CrossrefPubMedGoogle Scholar
  • 22 Giordano R, Picu A, Marinazzo E. et al. Metabolic and cardiovascular outcomesin patients with Cushing’s syndrome of different aetiologies during active disease and 1 year after remission. Clin Endocrinol (Oxf) 2011; 75: 354-360
    CrossrefPubMedGoogle Scholar
  • 23 Invitti C, Giraldi FP, Martin MD. et al. Diagnosis and management of Cushing’s syndrome: Results of an Italian multicentre study. J Clin Endocrinol Metab 1999; 84: 440-448
    PubMedGoogle Scholar
  • 24 Elena Valassi, Alicia Santos, Maria Yaneva. et al. The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 2011; 383-392
    PubMedGoogle Scholar
  • 25 Pirlich M, Biering H, Gerl H. et al. Loss ofbody cell mass in Cushing’s syndrome: Effect of treatment. J Clin Endocrinol Metab 2002; 87: 1078-1084
    PubMedGoogle Scholar
  • 26 Krsek M, Silha JV, Jezková J. et al. Adipokine levels in Cushing’s syndrome; Elevated resistin levels in femalepatients with Cushing’s syndrome. Clin Endocrinol (Oxf) 2004; 60: 350-357
    CrossrefPubMedGoogle Scholar